Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–6 of 6 results
Advanced filters: Author: Molly Gasperini Clear advanced filters
  • A critical goal in functional genomics is evaluating which non-coding elements contribute to gene expression, cellular function, and disease. Here the authors present a CRISPRi-based method using truncated guides disrupts transcription factor binding and enhancer activity across thousands of sites, expanding CRISPRi targeting scope for functional genomics and enabling efficient screening of repeated genomic elements

    • Molly M. Moore
    • Siddarth Wekhande
    • Fadi J. Najm
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-12
  • This Perspective from Jay Shendure's lab reviews the past decade's development of multiplexed assays for variant effects, and also comments on the potential of these experiments for the functional interpretation of genetic variation.

    • Molly Gasperini
    • Lea Starita
    • Jay Shendure
    Reviews
    Nature Protocols
    Volume: 11, P: 1782-1787
  • In this Review, Gasperini, Tome and Shendure discuss the evolving definitions of transcriptional enhancers, as well as diverse modern experimental tools to identify them. The authors describe how these diverse mindsets and methods provide differing but complementary insights into enhancers, each with notable strengths and caveats. They discuss how such views and approaches might be combined in a comprehensive catalogue of functional enhancers.

    • Molly Gasperini
    • Jacob M. Tome
    • Jay Shendure
    Reviews
    Nature Reviews Genetics
    Volume: 21, P: 292-310
  • Germline BRCA1 loss-of-function variants are associated with predisposition to early-onset breast and ovarian cancer; here the authors use CRISPR/Cas9 genome editing to functionally assess thousands of BRCA1 variants in order to facilitate the clinical interpretation of these variants.

    • Gregory M. Findlay
    • Riza M. Daza
    • Jay Shendure
    Research
    Nature
    Volume: 562, P: 217-222
  • CRISPR-based single-cell pooled screens that use linked barcodes suffer from lost sensitivity due to lentiviral template switching. The barcode-free CROP-seq design circumvents this problem.

    • Andrew J Hill
    • José L McFaline-Figueroa
    • Cole Trapnell
    Research
    Nature Methods
    Volume: 15, P: 271-274